Upcoming event
40th Annual EAU Congress
Back

Comparison of the efficacy and safety of tolterodine 2 mg and 4 mg combined with an α-blocker in men with lower urinary tract symptoms (LUTS) and overactive bladder: A randomized controlled trial

  • Kim T.H.,
  • Jung W.,
  • Suh Y.S.,
  • Yook S.,
  • Sung H.H.,
  • Lee K.-S.

Publication: Cited 2 times

https://www.ncbi.nlm.nih.gov/pubmed/26305143